This inventor holds 3 USPTO granted patents. Top assignees: Baxter Aktiengesellschaft, Baxter International Inc., Other. Active years: 2003-2006.
Company Filing History:
2 out of 67 
1 out of 2,531 
1 out of 834,411 Years Active: 2003-2006
Title: Rudolf Kneidinger: Innovator in Fibrin Conjugates
Introduction
Rudolf Kneidinger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biomedical engineering, particularly in the development of fibrin/fibrinogen-binding conjugates. With a total of 3 patents, his work focuses on enhancing the delivery of pharmaceutically active substances.
Latest Patents
Kneidinger's latest patents include innovative fibrin/fibrinogen-binding conjugates designed for the sustained release of active substances from fibrin clots. These conjugates consist of a fibrin/fibrinogen binding moiety that is either directly bound to a pharmaceutically active substance or linked via an intervening substance capturing moiety, such as an antibody. Additionally, these conjugates can be formulated as recombinant fusion proteins, incorporating a fibrin/fibrinogen binding moiety, such as the VEGF C-terminal domain, fused with wound-healing substances like leptin.
Career Highlights
Throughout his career, Kneidinger has worked with prominent companies in the biomedical sector, including Baxter Aktiengesellschaft and Baxter International Inc. His experience in these organizations has allowed him to refine his expertise in the development of innovative medical solutions.
Collaborations
Kneidinger has collaborated with esteemed colleagues, including Heinz Redl and Walter Fuerst. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Rudolf Kneidinger is a distinguished inventor whose work in fibrin/fibrinogen-binding conjugates has the potential to revolutionize drug delivery systems. His contributions to the field are marked by a commitment to innovation and collaboration.